Purpose/Hypothesis: Parkinson’s disease (PD) is a progressive, neurodegenerative disorder characterized by both motor and non ...

The past two decades have seen major advances in Alzheimer's disease research and clinical care, catalysed by the development of CSF and blood biomarkers and PET imaging that reliably detect amyloid β ...

Jean-Martin Charcot (1825-1893), the first major international clinical neurologist. In this celebration year, symposia, ...

The most common prodromal symptom of Parkinson disease among community-dwelling older adults was cognitive deficit, followed by subthreshold parkinsonism, urinary dysfunction, and olfactory ...

The longstanding partnership between The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Edmond J. Safra Foundation continues to open the door toward scientific advances and ...

Understanding the exposome reveals how environmental factors influence health through epigenetics and oxidative stress, ...

Symptoms of Parkinson’s disease, which afflicts around 1 million Americans, usually begin gradually and worsen over time.

For years, scientists have studied Parkinson’s but haven’t been able to figure out exactly what causes it. Without knowing ...

Introduction Parkinson’s disease (PD) is a chronic neurodegenerative condition that affects approximately 10 million people worldwide. As the second most common neurodegenerative disease, its ...

When a loved one is diagnosed with Parkinson’s disease, it can bring many new challenges and emotions. The condition affects ...

Parkinson's and Alzheimer's diseases are the two most common neurodegenerative disorders, affecting millions of people ...